US 12,465,488 B2
Device and method for controlling in-vivo pressure
Dan Rottenberg, Haifa (IL); Ori J. Braun, Palo Alto, CA (US); Avraham Aba Zakay, Zichron-Yaakov (IL); Ascher Shmulewitz, Tel-Aviv (IL); Yoram Rozy, Caesarea (IL); and Gad Keren, Kiryat-Ono (IL)
Assigned to V-Wave Ltd., Caesarea (IL)
Filed by V-Wave Ltd., Caesarea (IL)
Filed on Jul. 8, 2022, as Appl. No. 17/811,476.
Application 15/668,622 is a division of application No. 13/108,672, filed on May 16, 2011, granted, now 9,724,499, issued on Aug. 8, 2017.
Application 17/811,476 is a continuation of application No. 17/653,551, filed on Mar. 4, 2022, granted, now 11,382,747, issued on Jul. 12, 2022.
Application 17/653,551 is a continuation of application No. 16/672,420, filed on Nov. 1, 2019, granted, now 11,266,501, issued on Mar. 8, 2022.
Application 16/672,420 is a continuation of application No. 15/668,622, filed on Aug. 3, 2017, granted, now 10,463,490, issued on Nov. 5, 2019.
Application 13/108,672 is a continuation of application No. 10/597,666, granted, now 8,070,708, issued on Dec. 6, 2011, previously published as PCT/IL2005/000131, filed on Feb. 3, 2005.
Claims priority of provisional application 60/573,378, filed on May 24, 2004.
Claims priority of provisional application 60/541,267, filed on Feb. 3, 2004.
Prior Publication US 2022/0338989 A1, Oct. 27, 2022
Int. Cl. A61F 2/24 (2006.01); A61B 5/0215 (2006.01); A61B 17/00 (2006.01); A61M 27/00 (2006.01)
CPC A61F 2/2442 (2013.01) [A61B 5/0215 (2013.01); A61B 17/00234 (2013.01); A61M 27/002 (2013.01); A61B 2017/00243 (2013.01); A61B 2017/00252 (2013.01); A61B 2017/00575 (2013.01); A61B 2017/00592 (2013.01); A61B 2017/00606 (2013.01); A61F 2/24 (2013.01); A61F 2/2493 (2013.01)] 30 Claims
OG exemplary drawing
 
1. A device for implantation in an opening in a septal wall in a heart of a patient, the device comprising:
a core segment defining a passage, after implantation of the device, that enables flow to traverse from one side of the septal wall to another side of the septal wall, the core segment having a first diameter when deployed;
a first annular structure contiguous with the core segment; and
a second annular structure contiguous with the core segment,
wherein the device is collapsible, so that the core segment has a second diameter less than the first diameter to enable percutaneous delivery of the device to the heart of the patient, and
wherein the core segment comprises a tube that extends beyond the first annular structure or the second annular structure into an atrial chamber.